🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › New York › Greenburgh

Etid klinik pou Limfom Difize Gwo Selil B nan Greenburgh, NY

8 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Greenburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Ap rekriteFaz 2/3
  • New York Medical College ( Site 0113), Valhalla · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05139017

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • New York Medical College ( Site 1023), Valhalla · 5 mi lwen
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • New York Medical College, Valhalla · 5 mi lwen
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
Laj 65 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT06765317

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Ap rekriteFaz 1/2
  • New York Medical Center, Valhalla · 5 mi lwen
Laj 12 a 70 · Tout sèks · Mizajou Apr 15, 2026 · NCT04491370

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 1 bonè
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT04512716

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT06736613

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Ap rekriteFaz 2
  • New York Medical College, Valhalla · 5 mi lwen
Laj 3 a 31 · Tout sèks · Mizajou Aug 8, 2025 · NCT02393157

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Greenburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.